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Abstract
Background: MicroRNAs are the major class of gene-regulating molecules playing diverse roles
through sequence complementarity to target mRNAs at post-transcriptional level. Tightly
regulated expression and interaction of a multitude of genes for ovarian folliculogenesis could be
regulated by these miRNAs. Identification of them is the first step towards understanding miRNA-
guided gene regulation in different biological functions. Despite increasing efforts in miRNAs
identification across various species and diverse tissue types, little is known about bovine ovarian
miRNAs. Here, we report the identification and characterization of miRNAs expressed in the
bovine ovary through cloning, expression analysis and target prediction.
Results: The miRNA library (5'-independent ligation cloning method), which was constructed
from bovine ovary in this study, revealed cloning of 50 known and 24 novel miRNAs. Among all
identified miRNAs, 38 were found to be new for bovine and were derived from 43 distinct loci
showing characteristic secondary structure. While 22 miRNAs precursor loci were found to be
well conserved in more than one species, 16 were found to be bovine specific. Most of the miRNAs
were cloned multiple times, in which let-7a, let-7b, let-7c, miR-21, miR-23b, miR-24, miR-27a, miR-
126 and miR-143 were cloned 10, 28, 13, 4, 11, 7, 6, 4 and 11 times, respectively. Expression
analysis of all new and some annotated miRNAs in different intra-ovarian structures and in other
multiple tissues showed that some were present ubiquitously while others were differentially
expressed among different tissue types. Bta-miR-29a was localized in the follicular cells at different
developmental stages in the cyclic ovary. Bio-informatics prediction, screening and Gene Ontology
analysis of miRNAs targets identified several biological processes and pathways underlying the
ovarian function.
Conclusion: Results of this study suggest the presence of miRNAs in the bovine ovary, thereby
elucidate their potential role in regulating diverse molecular and physiological pathways underlying
the ovarian functionality. This information will give insights into bovine ovarian miRNAs, which can
be further characterized for their role in follicular development and female fertility as well.
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Background
Folliculogenesis is the result of series of complex and
coordinated processes, which include morphological and
functional changes in different types of follicular cells and
their interactions. Sequential recruitment, selection and
growth of the follicles, atresia, ovulation and luteolysis are
dynamically regulated events that occur on a cyclical basis
within the ovary. These processes are under control of
closely coordinated endocrine and paracrine factors to
develope a number of ovulatory follicles that are species
and breed dependent [1]. All those events entail substan-
tial changes and balance between many processes such as
the cell cycle, cellular growth, proliferation, differentia-
tion, angiogenesis, steroidogenesis and atresia to deter-
mine the ultimate fate of follicles. All of these steady state
cyclic changes are controlled by tightly regulated expres-
sion and interaction of a multitude of genes in different
compartments of the ovary (oocyte, cumulus granulosa,
mural granulosa cells and theca cells) to facilitate oocyte
development [2].
In oogenesis and embryo development, there are different
mechanisms regulating gene expression at the post-tran-
scriptional level. These include events of mRNA adenyla-
tion and deadenylation, the CAP structure at the 5' end of
the mRNA and the effective action of mRNA binding fac-
tors [3,4]. Recently, a new post-transcriptional gene regu-
lation is opened up after promising discovery of hundreds
of miRNAs in different mammalian species. Diverse
expression pattern of miRNAs and high number of their
potential target mRNAs suggests their involvement in the
regulation of various developmentally related genes at
post-transcriptional level [5-11]. The tiny (18-24 nt in
length) and single-stranded miRNAs are derived from pri-
mary transcripts termed as "pri-miRNAs", which have an
RNA hairpin structure of 60-120 nt with a mature miRNA
in one of the two strands. This hairpin in turn is cleaved
from the pri-miRNA in the nucleus by the double-strand-
specific ribonuclease, Drosha [12]. The resulting precursor
miRNA (or pre-miRNA) is transported to the cytoplasm
via a process that involves Exportin-5 [13] and subse-
quently cleaved by Dicer [14] to generate a short, double-
stranded (ds) RNA duplex. One of the strands of the
miRNA duplex is incorporated into a protein complex
termed RNA induced silencing complex (RISC). RISC is
guided by the incorporated miRNA strand to mRNAs con-
taining complementary sequences in 3' untranslated
region, which primarily results in inhibition of mRNA
translation [15]. Those mRNAs which are repressed by
miRNAs are further stored in the cytoplasmic foci called P-
bodies [16-18].
Several studies have shown the involvement of miRNAs in
animal development. Inhibition of miRNA biogenesis has
resulted in developmental arrest in mouse and fish [19-
21]. Similarly, loss of important miRNA processing
machinery, Dicer1 resulted in female infertility in mouse
[22,23]. Targeted knockdown of mir-17-5p and let-7p in
wild type mice revealed impaired corpus luteum (CL)
angiogenesis and decreased serum progesterone levels. In
the same study, injection of these miRNAs revealed the
restoration of vasculature within the CL and increased
progesterone levels [23]. In addition to loss-of-function
approach, efforts have been done to identity miRNAs by
cloning. For example, small RNA-cDNA libraries from the
ovaries of 2-wk-old and adult mice have generated a
number of miRNAs with potential role in ovarian func-
tion [24]. Subsequent study on ovarian miRNAs in mouse
showed the post-transcriptional regulation of CtBP1 gene
by miR-132 and miR-212 in cultured granulosa cells [25].
In addition to miRNA, several other non-coding small
RNAs including rapiRNAs, napiRNAs, rasiRNAs and
tncRNAs are identified and reported in different species
[26-28].
Bio-informatic approaches and construction of small
RNA-cDNA libraries from bovine adipose tissue, mam-
mary gland, embryo, thymus, small intestine, mesenteric
lymph node and abomasum lymph node have identified
most of presently annotated bovine miRNAs [29,30]. The
number of bovine miRNAs (117) in comparison to
Human (695), Chicken (475), Mouse (488), Chimpanzee
(595), Rhesus Monkey (463) in miRBase 12.0 are inade-
quate to disclose global miRNAs regulation of gene
expression for various biological functions and disease
conditions. Recently, we have shown the dynamics of
miRNAs expression during bovine oocyte maturation in
vitro using heterologous approach [31]. This together
with previous report in mouse supports the possible role
of miRNAs during follicular development and oocyte
growth. Identifying entire set as well as ovary-specific
miRNAs may lead to understanding miRNA-guided gene
regulation in the ovary. So, the present study has been
conducted to get insight into the miRNA population
present in bovine ovary by investigating their characteris-
tics, expression pattern and features of their target genes.
Results
Description of the bovine ovarian small RNA library
To identify miRNAs in the ovary, RNAs of 18 to 26 nt in
length from bovine ovarian small RNAs (~200 nt) were
purified, cloned, sequenced and analyzed. About 233 con-
catemer clones were sequenced to generate 479 sequences
(after discarding non-quality and self ligated linker
sequences). Of these 80 small RNA-cDNA sequences were
beyond the expected range of nucleotides (18-26nt) in
length. Only sequences of 18 nt or more in length were
subjected to detail analysis. Distribution of different
lengths of nucleotide sequences found in this library is
presented in figure 1. We categorized all identifiedBMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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sequences according to their properties as determined by
in-silico analysis based on the criteria reported elsewhere
for different types of small RNAs [26,27,32,33]. The 479
sequences identified in the library represented 41% miR-
NAs, 12% mRNA, 12% rRNA, 6.3% tRNA, 6.0% repeat
associated siRNA, 2.7% small antisense RNA, 3.5% tiny
noncoding RNA, 1% small nuclear RNA and 15.2%
sequences that did not match to bovine genome
(Figure 2).
Distinct miRNAs identified in the bovine ovary
In cDNA library a total of 196 sequences were found to be
miRNA like molecules, of which 74 revealed distinct miR-
NAs (Table 1, Additional file 1). Out of these 74 miRNAs,
36 were found to be reported in miRBase 12.0 for differ-
ent species including bovine, 14 are registered only for
other species and 24 were completely new. Of these 38
new bovine miRNAs, 15 miRNAs were identical or dif-
fered by only one or two nucleotides from known mam-
malian miRNAs. We denoted all the new miRNAs starting
with prefix 'bomir' followed by their homologue miRNA
number or by clone name in case of no sequence homol-
ogy. Already annotated miRNAs were named as they were
stated in miRBase.
Two miRNAs, namely: mir-22/22* and 140/140* which
are cloned from 5' fold back arm of the hairpin precursor,
have shown exact match to human miRNAs but not to
bovine as annotated in miRBase. So, previously annotated
bta-miR-22 and 140 seem to be miR-22* and miR-140*,
respectively. The number of times that each miRNA
cloned in the library ranged from 28 clones for let-7b to a
single clone (singleton) for 39 of the 73 miRNAs. All in
all, 22 of the 73 miRNAs were cloned for three or more
times (Figure 3, Additional file 1).
The corresponding bovine genomic sequences and their
locations were identified for each miRNA. The 5' or 3'
flanking genomic sequences were then tested for the abil-
ity to fold into canonical ~70-nt miRNA precursor hairpin
structures by using the MFOLD web server [34]. Small
RNA clones with proper positioning within an arm of the
hairpin suggest that they have been excised during dicer
processing in the cells. Nearly in all of those cases,
sequences were found to be conserved in different species
including the predicted precursors (Additional file 2). The
Bomir-652, which could not be located in bovine
genome, was found to be cloned for five times in the
library and share sequence homology with already identi-
fied miRNA in other species.
Genomic distribution, properties and clustering of new 
miRNAs
Genomic locations and properties of the new miRNAs are
shown in table 1. All newly identified bovine miRNAs
(except bomir-652) are corresponded to 43 distinct loci.
Putative precursor hairpin structures have been predicted
for all these 43 loci using genomic sequences flanked from
candidate miRNAs (Additional file 2). Thirty three of
these are found to be encoded by single copy miRNA
genes, whereas the other five (bomir-378, bomir-C0533-
5p, bomir-F0522-3p, bomir-A3341-3p and bomir-A4052-
5p) have multiple loci in the bovine genome (Additional
file 2). The analysis of the genomic positions of 61
sequences corresponding to 38 distinct new miRNA genes
showed that the majority (23 out of 44 loci) are localized
to intergenic regions and the rest corresponded to the
intragenic regions in either sense or antisense orientation
(Additional file 2). However, 11 sequences are found to
be exclusively from known intronic region.
Characterization of our miRNAs was done based on the
annotation in the bovine genome data base Ensembl 52:
Size distribution of 479 small RNAs sequences cloned from  the bovine ovary Figure 1
Size distribution of 479 small RNAs sequences cloned 
from the bovine ovary.
Frequency (%) of different types of RNA represented in the  library Figure 2
Frequency (%) of different types of RNA represented 
in the library.BMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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Table 1: List of new miRNAs cloned from bovine ovary
miR ID Length Homolog Copy Strand Sequence Genomic Locatione Transcript
bomir-22*/22-5pa 22 hsa-miR-22 3 +/- ACAGUUCUUCA
ACUGGCAGCUU
19:22901905:
22901926:1f
miR trans.
bomir140*/140-5pb 22 hsa-miR-140 1 + CAGUGGUUUUA
CCCUAUGGUAG
18:35987052:
35987073:1f
miR trans.
bomir-143-3p 22 ggo-miR-143 11 +/- UGAGAUGAAGC
ACUGUAGCUCG
7:60268857:
60268878:1f
Intergenic
bomir-152-5p 21 hsa-miR-152 1 - CCAAGUUCUG
UCAUGCACUGA
19:39650399:
39650419:-1f
Intragenic
bomir-193a-2-3pc 19 bta-miR193a 1 - GGGACUUUGU
AGGCCAGUU
14:889828:
889846:-1f
Intronic
bomir-378-1-3p 21 hsa-miR-378 1 + CUGGACUUGGA
GUCAGAAGGC
7:60536513:
60536533:1f
Intronic
bomir-378-2-5p 21 hsa-miR-378 - - + CUGGACUUGG
AGUCAGAAGGC
4:11116898:
11116918:1h
Intronic
bomir-382-3p 22 hsa-miR-382 1 - GAAUCCACCAC
GAACAACUUC
21:66031757:
66031777:-1f
Intronic
bomir-409-5p 22 hsa-miR-409 2 - GGGGUUCACCG
AGCAACAUUC
21:66042162:
66042182:-1f
Intronic
bomir-424-3p 22 hsa-miR-424* 1 - CAAAACGUGAG
GCGCUGCUAU
Un.04.53:446874:
446894:-1f
Intronic
bomir-503-3p 23 mmu-miR-503 1 + UGCAGUACUGU
UCCCGCUGCUA
Un.004.53:446563:
446584:1f
Intergenic
bomir-542-3p 23 hsa-miR-542 1 + UCUCGUGACAU
GAUGAUCCCCGA
Un.004.53:441604:
441626:1f
Intergenic
bomir-574-5p 22 hsa-miR-574 1 - UGUGGGUGUGU
GCAUGUGCGUG
16:59370677:
59370698:-1f
Intergenic
bomir-652-3pd 21 hsa-miR-652 5 + CACAACCCTA
GTGGCGCCATT
(from H. sap.) -----
bomir-940-5p 18 hsa-miR-940 1 - GCAGGGCCC
CCGCUCCCC
20:75274475:
75274492:-1h
Intergenic
bomir-F0131-5p 18 mmu-miR-667 1 + GGGGCGGGG
GGGCGGGUG
7:10905965:
10905982:1h
Intergenic
bomir-F0132-5p 19 hsa-miR-1469 1 + AGCCCGGGC
CCCUCCCCUG
7:13891718:
13891736:1h
Intragenic
bomir-H0121-3p 19 hsa-miR-1471 1 + CUUCCCGUG
UGUUGAGCC
18:7202610:
7202627:1h
Intergenic
bomir-F0244-5p 19 osa-miR1423 1 - GCUACUACC
GAUUGGAUGG
12:45758300:
45758318:-1g
Intergenic
bomir-H0222-3p 22 cre-miR1172.1 1 - GGACGGCGGCA
GCGCCGGGGCG
29:41706141:
41706159:-1f
Intergenic
bomir-A0321-3p 18 mml-miR-638 1 + AGCGCCGCC
GGCCGCACC
19:39110507:
39110524:1g
Intronic
bomir-C0533-5p 20 oan-miR-1418* 1 + CGGGACCGGG
GUCCGGUGCG
18:59928733:
59928752:1f
Intergenic
21:52041918:
52041937:-1f
Intergenic
bomir-F0522-1-3p 19 hsa-miR-1234 1 + GGUGGGGUGG
GGGGGUUGG
21:35870379:
35870397:1h
Intergenic
22:59347395:
59347413:1h
Intronic
bomir-B0821-5p 21 oan-miR-1394 1 - GUCCCCGGGGC
UCCCGCCGGC
20:19373746:
19373766:-1h
Intergenic
bomir-F1351-3p 20 gga-miR-1607 3 + GCCCCGGCCG
CUCCCGGCCU
25:41129497:
41129516:1h
Intergenic
bomir-F1353-5p 20 dre-miR-430c 1 + AUCUUUGGGC
UAGGUUAGUU
28:27885036:
27885055:1h
Intronic
bomir-D1431-5p 22 pta-miR1310 2 - GGCGACGGAGG
CGCGACCCCCC
12:75102030:
75102051:-1g
Intergenic
bomir-C1511-5p 20 hsa-miR-877 1 + GUGGAGGAGA
AUGCCCGGGG
Un.04.1059:20639:
20658:1h
Intronic
bomir-F1821-3p 21 hsa-miR-631 1 + AGCCCUGGCCC
UGCCAUCGUG
Un.04.152:123191:
123211:1h
IntronicBMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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Btau_4.0 [35]. Bomir-F0522-3p and bomir-A4052-5p
were mapped to both intergenic and intronic locations.
Bomir-F0132-5p (sense), bomir-E2664-3p (antisense)
and bomir-A4052-5p (antisense) are originated from the
exons of protein-coding genes. While searching the
genomic location for all miRNAs, we found six new
genomic locations for annotated miRNAs like bta-mir-
106, 24, 26, 199a and let-7b (Additional file 1).
All the 50 new genomic loci were found to be distributed
in 19 chromosomes (Chr.) namely: Chr. 3, 4, 5, 7, 8, 9,
11, 12, 14, 16, 18, 19, 20, 21, 22, 25, 26, 28 and 29. How-
ever, eight loci were found to be mapped to unknown
chromosome in the Ensembl 52: Btau_4.0 (end note).
Among all newly identified loci, eight miRNA genes were
found to be located on Chr. 18 and five miRNAs found on
Chr. 7 and 21. Further analysis of the already annotated
miRNAs and the newly predicted loci has revealed six
miRNAs gene clusters which were mapped within < 10 kb.
This clusters are i) bta-miR-10a and bomiR-A0321 on
Chr. 19; ii) bta-miR-23b, bta-miR-27b and bta-miR-24-3
on Chr. 8; iii) bta-let-7a-3 and let 7b-2-3P on Chr. 5; iv)
bomiR-A4052-1 and bomiR-C0533 on Chr. 18; v) bta-
miR-487a, bta-miR-487-b, bomiR-382 and bomiR-409
on Chr. 21; vi) bomiR-C0533-2 and bomiR-A4052-2 on
Chr. 21.
To determine whether our new miRNAs are conserved
among closely related species, we have searched for
homology for precursor sequence in the ENSEMBL
genome databases. Results revealed that 17 precursor loci
(out of 43 loci for 38 new bovine miRNAs) were found to
be conserved in at least six species. While five miRNAs
(bomiR-F0244, bomiR-A0321, bomiR-F2531, bomiR-
D3011 and bomiR-A3711) were found to be conserved in
bomir-C1931-5p 23 gma-miR1523 1 + CCUGCUGAUCU
CACAUUAAUUCA
26:12405838:
12405860:1h
Intergenic
bomir-A2143-3p 18 oan-miR-181c* 1 + CGGCAGAUG
AAGUCCAUC
16:47801336:
47801353:1h
Intronic
bomir-F2422-5p 20 hsa-miR-659 1 + GGUGGGAGGG
UCCCACCGAG
18:53584142:
53584161:1h
Intragenic
bomir-F2531-3p 18 ppt-miR1030i 3 + UGGUGGAGA
UGCCGGGGA
8:77307661:
77307678:1g
Intergenic
bomir-G2511-3p 18 bmo-miR-92 1 + AGGCGGGCC
GGGGUUGGA
18:41190536:
41190553:1h
Intergenic
bomir-E2664-3p 20 mml-miR-638 1 - AGGGCGGGCG
GCGACUGGAA
18:64361001:
64361020:-1h
Intragenic
bomir-D3011-3p 21 mml-miR-650b 1 + CCGAGUGCUC
CCGCGAGCGCU
18:39424938:
39424958:1g
Intragenic
bomir-A3341-1-3p 22 bta-miR-487a 1 + GUGGCUGUCCC
UGGAGGUGGG
3:124988008:
124988028:1h
Intergenic
Un.04.4799:1335:
1355:1h
Intergenic
bomir-A3711-5p 19 hsa-miR-937 2 + UUCCGCGCUC
UACGCCAGC
9:63475804:
63475822:1g
Intergenic
bomir-A4052-1-5p 19 hsa-miR-615 1 + GGGAGCCUCG
GUUGGCCUC
18:59928630:
59928648:1f
Intergenic
21:52042022:
52042040:-1f
Intragenic
Un.04.2732:16069:
16087:-1f
Intergenic
a: Cloned sequence is homolog to has-miR 22 but not to bta-miR-22, may bta-miR-22 presented in miRBase v. 12 is bta-miR-22*, b: Cloned 
sequence is homologue to has-miR-140 but not to bta-miR-140, may bta-miR-140 presented in miRBase v. 12 is bta-miR-140*
c: Sequence is smaller than bta-miR-193a and has different genomic locus. d: Sequence does not match to bovine genome, e: Genomic location 
presenting chromosome number with start and end position along with sense/antisense orientation by 1/-1 of cloned mature sequence. 
Conservation pattern of the predicted precursor sequences from flanking bovine genome sequence is indicated by- f: found in more than 6 
mammalian species, g: present at least in 2 species, h: only in bovine.
Table 1: List of new miRNAs cloned from bovine ovary (Continued)
Frequency (%) of cloned miRNAs along with their copy  number Figure 3
Frequency (%) of cloned miRNAs along with their 
copy number.BMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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at least two species, 21 miRNA loci were specific to
bovine. All of the newly cloned miRNAs were found to be
conserved as mature sequences in the genome of different
species. Thermo-dynamically stable hairpin structures
were found for those conserved and new miRNAs as
shown in additional file 2.
Other small RNAs and their genomic properties found in 
the library
Analysis of small RNA library in the present study has ena-
bled us to identify 57 different endogenous siRNAs. We
categorized them broadly into two groups, namely: 29
sequences composed of 27 distinct RNAs derived from
genomic repetitive region as repeat associated small inter-
fering RNAs (rasiRNAs) and other 30 RNAs associated to
non repetitive regions as non-repeat associated small
interfering RNAs (nasiRNAs). According to their sequence
properties 13 out of 30 nasiRNAs were found to be natural
antisense transcripts with ~20 nt in length. Therefore,
since they seem to be endogenous siRNAs, we denoted
them as small antisense RNAs (santRNAs) and the rest 17
as tiny non-coding RNAs (tncRNAs). Size ranges for rasiR-
NAs were 18-28 nt (with mean ± SD 21.5 ± 3.1 nt), which
did not revealed a sharp size distribution characteristic.
However, for the santRNAs and tncRNAs the size distribu-
tion was 19.6 ± 1.9 and 19.5 ± 1.1 nt, respectively. Cloned
rasiRNAs were found to be distributed on various chro-
mosomes and mapped to repeat sequences mostly corre-
sponding to retrotransposons in both sense and antisense
orientation. Total numbers of hits for 27 rasiRNAs were
581 (ranging from 4 to100). Seventy five percent of the
rasiRNAs were found to have preference for uridine and
adenine residues in either 3' or 5' end position. While
seven of the santRNAs were precisely mapped to inter-
genic region, six fitted to intronic region. All the 13 sant-
RNAs were cloned as antisense orientation to the genome
or intron of the protein coding genes on 12 different chro-
mosomes.
Secondary structure analysis of all santRNAs revealed no
characteristic hairpin as found for the miRNAs. While
eleven tncRNAs were mapped to intergenic region, five
were mapped to intronic and two to exonic regions. Two
of the seventeen tncRNAs were predicted to form poten-
tial fold back structures like the miRNAs. However, these
putative tncRNA precursor structures deviated signifi-
cantly from the miRNA hairpins in key features and they
were found to be poorly conserved in closely related spe-
cies.
Detection and expression of miRNAs in the ovary and 
other bovine tissues
The expression of all new miRNAs including nine anno-
tated miRNAs (let-7b, mir-15b, mir-18a, mir-29a, mir-
125b, mir-126, mir-145, mir-199a and mir-222) in 11 dif-
ferent bovine tissues were analyzed using semi-quantita-
tive RT-PCR (details in Figure 4, Table 2 and Additional
file 2). As small RNAs were cloned in the library derived
from all compartments of the ovary, samples from ovar-
ian cortex, cumulus cells and matured corpus luteum were
used to determine the sub-cellular expression profile of
the new miRNA using RT-PCR (Table 2). This is because
of two facts: firstly, the bovine ovary is continuously
changing throughout the process of folliculogenesis and
secondly, the distinct nature of function of intra-ovarian
cells and tissues compartments in the ovary.
Of all 47 miRNAs (38 new and 9 already annotated miR-
NAs) 44 were detected in both ovarian cells and multiple
tissues. Five miRNAs (bta-mir-126, bomir-F0132, bomir-
A0321 and bomir-F1821) were found to be expressed at
similar level in all experimental tissues. Seven miRNAs
(bta-mir-18a, bta-mir-29a, bomir-140, bta-mir-199,
bomir-378, bomir-F0132 and bomir-F2422) were found
to be expressed at relatively higher levels in ovarian corti-
cal portion (Table 2). On the other hand, all undetected
or less expressed miRNAs in ovarian cortex were found to
be highly expressed in cumulus cells or corpus luteum.
Most of the miRNAs were found to be differentially
expressed between adult ovarian tissues and fetal ovary.
Among them bta-mir-15b, bomir-409, bomir-652, bomir-
C0533 and bomir-D1431 were highly expressed in the
fetal ovary compared to that of adult ovarian cortex. How-
ever, bta-mir-29a, bta-mir-199 and bomir-F2422 were
found to be expressed at higher level in the adult ovarian
cortex than that of the fetal ovary (Table 2). Bta-mir-125b,
bta-mir-222, bomir-542, bomir-652, bomir-H0222,
bomir-F0522, bomir-C1931 and bomir-A2143 were
found to be expressed at very low level or not detected at
all in the ovarian cortex. However, their abundance was
higher in the cumulus cells and matured corpus luteum.
The expression of bta-mir-222 was detected exclusively in
the cumulus cells. In addition, higher expression of bta-
mir-125b, bomir-409, bomir-503 and bomir-F0244 was
also observed in the cumulus cells. The expression of
bomir-652, bomir-H0222, bomir-C1931 and bomir-
A2143 was higher in the corpus luteum.
Moreover, higher expression level of different miRNAs in
various reproductive tissues was also observed. This
includes bomir-940 in the oviduct; bta-mir-222, bomir-
F2422 and bomir-G2511 in the uterus; and bta-mir-29a,
bomir-143, bta-mir-145, bta-mir-199, bomir-542 in the
placenta. All these investigated miRNAs were detected at
least in one of the non-ovarian somatic tissues including
heart, liver, lung and spleen (Table 2). The RT-PCR analy-
sis did not confirm the expression of three novel miRNAs
(bomir-F0131, bomir-H0121 and bomir-B0821) in any
of the tissues under investigation (image not shown).
In order to elucidate the cellular localization of one
miRNA, bta-miR-29a was selected due to its differentialBMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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Table 2: Detection and expression of selected miRNAs in multiple tissues
miRNAs Ovarya Fetal Ovaryb Cumulus 
cells
Corpus 
luteumc
Oviduct Uterus Placenta Heart Liver Lung Spleen
5s rRNA +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++
U6 RNA +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++
bta-let7b ++ +++ +++ +++ ++ + +++ ++ + ++ +++
bta-mir-15b + +++ +++ +++ +++ +++ +++ +++ +++ + +++
bta-mir-18a +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++
bomir-22*/22-5p + + + - - - - + - + +
bta-mir-29a +++ - +++ - - - +++ +++ + ++ ++
bta-mir-125b - ++ +++ ++ ++ + ++ ++ - +++ +
bta-mir-126 ++ +++ ++ +++ +++ +++ +++ +++ +++ +++ +++
bomir140*/140-5p +++ +++ +++ ++ ++ ++ ++ ++ ++ - ++
bomir-143-3p ++ +++ + ++ + + +++ ++ + + ++
bta-mir-145 ++ +++ - ++ - - +++ ++ ++ - +++
bomir-152-5p ++ ++ - ++ +++ +++ ++ ++ +++ +++ +++
bomir-193a-2-3p + ++ ++ - ++ ++ ++ + + ++ ++
Bta-mir-199 +++ ++ +++ ++ ++ ++ +++ +++ ++ +++ +++
bta-mir-222 - - +++ - - ++ - - + + +
bomir-378-3p +++ +++ - - ++ +++ + ++ + + -
bomir-382-3p + - - - +++ +++ +++ +++ - - +++
bomir-409-5p + +++ +++ ++ +++ +++ +++ +++ +++ +++ ++
bomir-424-3p ++ - - - + ++ - - ++ - +
bomir-503-3p ++ +++ +++ ++ + + ++ ++ + ++ ++
bomir-542-3p - ++ ++ ++ +++ ++ +++ ++ ++ + +
bomir-574-5p + + - + + ++ ++ ++ ++ ++ ++
bomir-652-3p + +++ - +++ ++ +++ - - ++ - -
bomir-940-5p + - - - +++ + - + +++ ++ -
bomir-F0132-5p +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++
bomir-F0244-5p + ++ +++ ++ + ++ ++ + ++ + +
bomir-H0222-3p - ++ - +++ + + ++ ++ - + +
bomir-A0321-3p ++ ++ ++ ++ ++ ++ ++ ++ ++ + ++
bomir-C0533-5p + +++ ++ + - + + + - - -
bomir-F0522-3p - - ++ ++ - - - + - - -
bomir-F1351-3p ++ - - +++ ++ +++ + +++ +++ ++ +++
bomir-F1353-5p ++ ++ - ++ + +++ +++ + +++ - +
bomir-D1431-5p ++ +++ ++ +++ ++ + ++ +++ - + -
bomir-C1511-5p + + - + ++ ++ + ++ ++ + +
bomir-F1821-3p ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
bomir-C1931-5p + ++ - +++ +++ +++ +++ +++ +++ - +++
bomir-A2143-3p - ++ - +++ +++ +++ ++ ++ ++ ++ +++
bomir-F2422-5p +++ - - + + +++ - - ++ - +
bomir-F2531-3p + - - + ++ ++ + +++ ++ + -
bomir-G2511-3p + - - + + +++ + +++ ++ ++ -
bomir-E2664-3p ++ ++ ++ ++ + ++ ++ + ++ + ++
bomir-D3011-3p + + ++ + + + + + + ++ +
bomir-A3341-3p + + + + + + + + + + +
bomir-A3711-5p + + - + + + +++ + + + +
bomir-A4052-5p + + - ++ ++ ++ ++ ++ +++ ++ ++
Expression profiles of 44 miRNAs including all new miRNAs in multiple tissues by PCR approach. Amplicons were analyzed on 2% agarose gel. 5S 
rRNAs and U6 RNA were used as a loading control. Relative band intensity was categorized into four groups like '+++' for Strong signal, '++' for 
Medium signal, '+' for Weak signal or smear like product and '-' for not detected by comparing the expression signal of each miRNA to the 
expression level of 5S rRNA and U6 RNA. a: Ovarian cortex with no visible corpus luteum, b: Ovary from fetus at about 5th month of pregnancy, c: 
Mature corpus luteum from the same Ovary.BMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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expression between adult and fetal ovary, which are dis-
tinct in their functional activity. Accordingly, in-situ local-
ization of this miRNA in the sections of bovine ovarian
follicle revealed its expression in the different intra-ovar-
ian cells (theca, mural granulosa, cumulus granulosa and
oocyte) of different stages of development including pri-
mordial, primary, growing and matured/tertiary follicles
(Figure 5). Stable expression was detected in the whole
mount cumulus-oocyte-complexes derived from the folli-
cles of more than 8 mm in diameter. In the semi-quanti-
tative RT-PCR data, expression of this miRNA was found
in the cortex region of the adult ovary where follicles with
cumulus cells are residing. Moreover, the expression of
this miRNA was detected further until early stage of cor-
pus luteum (Figure 5), but very low or no expression in
the matured corpus luteum (Figure 4).
Prediction and functional categorization of cloned miRNA 
targets
The goal of this prediction and analysis was to find the
major biological processes and signaling pathways in the
ovary that are most likely affected by a group of miRNAs.
Even though there were many potential target genes pre-
dicted for the cloned miRNAs, several filtering and screen-
ing procedures (see materials and methods) have enabled
us to generate a comprehensive target list consisting of
115 potential genes from all the predicted targets (Addi-
tional file 3). From this screened target set, we found that
let-7b, mir-15b, mir-18a, mir-29a, mir-101, mir-125b,
mir-126, mir-143, mir-145, mir-199a and mir-222 to
have the highest number and overlapping targets (Figure
6). Interestingly, we found that all of these targeting miR-
NAs were represented at higher frequency in our con-
structed library.
Detailed Gene Ontology (GO) analysis of the screened
and sub-sets of miRNAs target genes were found to be
associated with reproductive system development, func-
tion and disorders. These include cell cycle, morphology,
cell death, cell to cell signaling, cellular growth, develop-
ment and proliferation, DNA replication, recombination
& repair, endocrine system disorder and different path-
ways underlying the ovarian functions. To further eluci-
date the specific functions of these genes, a detailed
pathway analysis was performed using Ingenuity Pathway
Analysis (Redwood City, California) for all target sets (Fig-
ure 7) as well as for the sub-set of genes (Table 3, Addi-
tional file 3).
Discussion
Identification of small RNAs
MicroRNAs play an integral part of animal gene regulatory
networks as one of the most abundant classes of gene reg-
ulators. They are estimated to comprise 1-5% of animal
genes [8,36,37] or a given genome could encode nearly
thousands of miRNAs [36]. Moreover, a typical miRNA
regulates hundreds of target genes [38-41] and altogether
they could target a large proportion of genes up to 30% of
the genome [42]. Changes in the expression of even a sin-
gle miRNA could have a significant impact on the out-
come of diverse cellular activities regulated by the product
of those genes. Beyond the strict conservation of miRNAs
across different species, some miRNAs appear to be spe-
cies specific [32,36,43]. Compared with computational or
heterologus approaches, direct cloning has the advantage
of identifying non-conserved and new miRNAs.
Our cloning and expression analysis led to the identifica-
tion of 74 miRNAs out of which 38 are new in bovine.
Mature sequences were found to be conserved in closely
related species, but when considering precursor sequence
only 51% was found to be conserved in human, mouse,
rat, dog, horse and also in other non-mammalian verte-
brates. However, in the present study, 17 miRNA precur-
sors corresponding to 21 genomic loci were found to be
not conserved (Table 1). This could be either due to the
lack of sequences in draft genome assembly or these miR-
NAs are bovine specific. The genomic properties of our
new miRNAs showed that they are derived from exon,
intron and intergenic region. This may suggest that these
miRNAs can be transcribed in parallel with their host tran-
scripts. In addition, two different transcription classes of
miRNAs ('exonic' and 'intronic') recognized here may
require somewhat different mechanisms of bio-genesis as
Detection and expression analysis of selected miRNAs in  multiple tissues Figure 4
Detection and expression analysis of selected miR-
NAs in multiple tissues. Expression profiles of some rep-
resentative miRNAs (out of detected 44 miRNAs) in multiple 
tissues by PCR approach. While the figures are presented in 
the additional file 2 and the expression for all are summa-
rized in the table 2. Amplicons were analyzed on 2% agarose 
gel. 5S rRNAs and U6 RNA were used as a loading control. 
A DNA ladder (M) indicating the size of the fragments (50-
100-150 nt) on each side. Ovary denotes only the ovarian 
cortex without corpus luteum.BMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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stated previously [44]. Discovery of six clusters composed
of 15 miRNA genes on six chromosomes showed that
these closely located host genes may share the same cis-
regulatory elements and the miRNAs within the clusters
might be expressed in the same tissues or at the same
developmental or physiological stage.
The representation of many known and novel miRNAs in
this single library indicates the presence of potential miR-
NAs, which are not yet discovered. Both in-depth analysis
of the existing library and cell-type-specific analysis of
individual miRNAs will give insight into the functional
mechanisms and pathways involved in ovarian folliculo-
genesis in particular and female fertility in general.
Along with the miRNAs several types of endogenous small
interfering RNAs were identified in the present study.
Among them, 27 distinct rasiRNAs represented the fre-
quent class of small RNAs. Thirteen RNAs were classified
as small antisense RNAs, while 17 small RNAs were tiny
non-coding RNAs. The small RNA cloning and profiling
from another study revealed less representation of that
group of rasiRNAs compared to the miRNAs [33]. The
properties we identified for rasiRNAs support the notion
In-situ detection of mir-29a in the ovarian sections and whole mount COCs Figure 5
In-situ detection of mir-29a in the ovarian sections and whole mount COCs. Bovine ovarian cryo-sections and 
whole mount cumulus-oocyte complexes were in situ hybridized with 3'-digoxigenin labeled locked nucleic acid (LNA) micro-
RNA probes for miR-29a (1), U6 RNA (2) and scrambled miRNA (3). BL- Basement Laminae, TI- Theca Interna, TE- Theca 
Externa, GR- Multiple layers of Granulosa, ZP-Zona Pellucida, OO-Oocyte, CR- Corona Radiata, AN-Antrum of the follicle, 
PT- Presumptive theca in the growing follicle.BMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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Eleven miRNAs with highest number of screened target genes (sub-set miRNAs targets) Figure 6
Eleven miRNAs with highest number of screened target genes (sub-set miRNAs targets). Each circle representing 
one miRNAs and the surrounding genes are targeted by that miRNA. Genes shared by the different circles highlighted as blue 
(overlapping genes between miRNAs), which are commonly targeted by the corresponding miRNAs.
Table 3: Ingenuity analysis of the genes targeted by top eleven screened miRNAs
miRNAs Functions and disease categories enriched with the selected 
miRNA targets
Canonical Pathways enriched with the selected 
miRNA targets
Let-7b Tissue morphology, cellular growth and proliferation, endocrine system 
disorders
IGF-1 signaling, hepatic fibrosis/hepatic stellate cell 
activation
mir-15b cell death, connective tissue development and function, cell cycle p53 signaling, PPARα/RXR activation
mir-18a Cell cycles, cellular function, endocrine system development Cell cycle: G1/S checkpoint regulation,
TGF-β signaling
mir-29a Reproductive system development and function, organ development, 
endocrine system development
Ephrin receptor signaling
Aminophosphonate metabolism
mir-101 Endocrine system development, lipid metabolism, small molecule 
biochemistry
C21-steroid hormone metabolism, Androgen and 
estrogen metabolism
mir-125b Inflammatory response, cell cycle, cellular function and maintenance LPS/IL-1 Mediated inhibition of RXR function, LXR/RXR 
activation
mir-126 Cellular movement, Endocrine system disorders, cell mediated immune 
response
Pro-apoptosis, PXR/PXR activation
mir-143 Cellular growth and proliferation, DNA replication, recombination and 
repair, gene expression
G1/S transition of the cell cycle, p53 signaling
mir-145 Reproductive system diseases, reproductive system development and 
function, cell death
BMP signaling pathway, VEGF signaling
mir-199a Cellular development, cell death, cellular growth and proliferation Cell cycle: G2/M DNA damage checkpoint regulation, p38 
MAPK signaling
mir-222 Cellular development, reproductive system development and function, cell 
death
IGF-1 signaling, Axonal guidance signaling
Eleven top miRNAs targeting highest number of genes from our screened and filtered all predicted targets and their top Gene Ontology categories 
and pathways based on Fisher' Exact P-value (< 0.05) are presented in the table. For detail figures see additional file 3.BMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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that they are presumably emerged from dsRNA produced
by annealing of sense and antisense transcripts that con-
tain repeat sequences related to transposable elements
[27]. These rasiRNAs are known to repress the repeat
sequences at the transcriptional or post-transcriptional
level and maintain a centromeric heterochromatic struc-
ture [45]. Identity and properties of new types of small
RNAs in the present study showed the presence of diverse
modes of small RNA-mediated gene regulation in bovine
ovary, as reported in other species [26]. Therefore, identi-
fication and characterization of other small RNAs and
their expression patterns are important for elucidating
detailed gene regulatory networks involved in the ovary.
So, all these endogenous small interfering RNAs need to
be further characterized to elucidate their cellular func-
tions.
Expression of miRNAs in diverse tissue types
Expression analysis of 44 miRNAs in different ovarian
cells and tissues types has enabled us to determine their
site of action in terms of tissue specific abundance as well
as functional regulation (Table 2). We have detected
nearly all of these miRNAs in at least one part of the entire
ovary and other somatic tissues. In the present study,
some miRNAs appear to be extremely tissue specific. For
example; bomir-C0533 and bomir-F0522 were found to
be exclusively expressed in ovarian tissues suggesting their
potential role in ovary-specific miRNA-dependent regula-
tory processes. Five miRNAs (miR-29a, miR-125b, bomir-
409, bomir-503 and bomir-F0244) were found to be
highly abundant in the cumulus cells and four (bomir-
652, bomir-H0222, bomir-C1931 and bomir-A2143) in
corpus luteum. These cumulus enriched miRNAs in the
present study may represent those miRNAs with potential
Top biological function, disease categories and pathways enriched with predicted and screened miRNA target genes Figure 7
Top biological function, disease categories and pathways enriched with predicted and screened miRNA target 
genes. A. Top biological functions and disease categories and B. pathways enriched with predicted and screened miRNA target 
genes. Ratio is the number of affected genes to total number of genes in the pathway. Threshold p < 0.05 is shown as yellow 
line. Bars that are above the line indicate significant enrichment of a functional category or pathway.BMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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association with the regulation of cumulus secreted fac-
tors, which are important for cumulus-oocyte communi-
cation and subsequent oocyte development. Similar study
in mouse showed hormonal regulation of miRNAs expres-
sion in preovulatory mural granulosa cell [25].
Altered expression of various ovary related genes was
reported in ovaries from fetal, new born and adult ani-
mals [46-49]. Furthermore, alteration in expression of
small RNAs has been addressed at different stages of
mouse ovary [24]. Similarly, in the present study we
found differential expression of mir-29a, bomir-140, mir-
199, mir-378, bomir-F0132 and bomir-F2422 in the ovar-
ian cortical portion between fetal and adult cows. This
may indicate their possible involvement in regulating fol-
licular development in the adult cyclic ovarian function.
This notion was further supported by higher detection of
miR-29a in different follicular cells (theca, cumulus-gran-
ulosa, and oocyte) of adult ovary by in situ hybridization
(Figure 5) and higher expression in cumulus cells by RT-
PCR but no detection in the fetal ovary. The expression of
miRNAs in ovarian cells is reported to be regulated by FSH
and LH/hCG [25,50] which functions in the cyclic ovary
but not in fetal ovary [51]. Moreover, most of the targets
predicted for this miRNA (Figure 6) are known to be
involved in various cyclic adult ovarian functions.
Noticeable expression level of miR-29a was found in dif-
ferent phases of corpus luteum (CL) development.
According to RT-PCR and in situ hybridization results,
expression of miR-29a was detected in the early phase CL
but not in mid phase (matured) CL. These two phases of
CL development are known to vary in multiple aspects of
luteal physiology, angiogenesis and sensitivity to luteo-
lytic actions, which are accompanied by differential
expression of multiple genes [52-55]. Bovine corpus
luteum is reported to be resistant to luteolysis by exoge-
nous PGF2α in early stage of CL (before Day 5) due to dif-
ferential expression of genes associated with the PGF2α
receptor [55]. Considering these facts and restricted
expression of miR-29a in early phase of CL in the present
study, it is possible to suggest that miR-29a is involved in
gene regulatory action during early phase of CL. All in all,
our results on miR-29a may elucidate the potential
involvement of this regulatory miRNA in growth and dif-
ferentiation of cumulus cells, endocrine regulation of
theca cells and early luteinisation in cyclic ovary.
Cloning, determining potential secondary structures and
expression analysis of all new miRNAs in multiple tissues
indicate their tissue specific existence and regulation of
gene expression. Only 7.8% of the new miRNAs could not
be detected by the RT-PCR procedure in various reproduc-
tive tissues. This may be due to the fact that these tran-
scripts were cloned at lower frequency (only once)
showing their lower abundance and subsequent difficulty
to detect them [30]. In general, the expression profiling
analysis in the present study revealed that our cloned miR-
NAs were either ubiquitously expressed in multiple tissues
or preferentially expressed in a few tissues including the
intra-ovarian cells and tissues.
Features of predicted target genes
Multiple genes contributing to mammalian folliculogene-
sis have been identified in mouse knockout study [56].
Primarily, oocyte-specific transcriptional regulators such
as Figla, Nobox, Sohlh1 and Lhx8, oocyte-secreted factors
such as Gdf9 and Bmp15, as well as genes expressed in the
granulosa and cumulus cells (FSHR  and  PTX3) were
found to initiate and control follicular growth [56,57].
Among the key intra-ovarian factors, the transforming
growth factor β (TGFβ) family members, of which bone
morphogenetic protein-4 have been identified as regulators
of primordial germ cell generation [58].
In response to FSH, the granulosa cell-derived factors such
as kit ligand, transforming growth factor alfa (TGF-α) and
epidermal growth factor (EGF) activate the resting follicu-
lar growth. The interactions between ovarian germ and
somatic cells (granulosa cells and the oocytes) and expres-
sion of several intra-ovarian autocrine/paracrine regula-
tors (FSH, estrogen and androgen receptors) are the major
contributing factors in the ovary leading to preantral and
antral follicles development [59].
During follicle growth, IGF system works in synergy with
gonadotrophins (follicle-stimulating hormone and
luteinising hormone) to regulate proliferation and differ-
entiation of granulosa and theca cells [60,61]. In addition,
it has been shown that the processes of follicular dynam-
ics (Recruitment, selection, dominance and ovulation) are
associated with temporal changes of peripheral gonado-
tropins concentration and IGF  system [62-68]. All the
above-mentioned genes are represented in our predicted
and analyzed targets. Altogether 115 genes were among
potential target genes of our identified miRNA. These tar-
get genes are already experimentally validated for poten-
tial ovary related functions in different mammalian
species (references in additional file 3). Interestingly, sev-
eral well-known target genes including IRS1, IGFBP3,
DNMT3A, HOXA9, TNF, etc. which are identified by our
new screening approach, were already validated in wet lab
experiments and reported as targets of multiple miRNAs
(miR-145, miR-125b, miR-126 and miR-29) [69-73].
Accordingly these studies have elucidated the potential
involvement of these miRNAs in broad class of functions
related to apoptosis, differentiation signal, cell differenti-
ation, tumorogenesis, DNA methylation and innate
immune responses.BMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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Gonadotropins, intra-ovarian mediators and their recep-
tors which are identified as target genes for our miRNAs
might mediate important intracellular actions necessary
for normal follicular development and other ovarian
functions. Alterations in the expression of these mediators
by miRNAs will result in various ovarian dysfunctions
causing infertility, polycystic ovary syndrome and tumor-
igenesis. Recent evidences also support our hypothesis,
where at least six of our 11 top ranked ovarian miRNAs
were found to be related to cancer or tumors in the ovary.
For example, miR-199a, miR-145, miR-125b and let-7
clusters were found to be the most differentially regulated
miRNAs in human ovarian cancer [74,75]. While miR-
145 [76] and mir-199a [77] have recently been shown to
be down-modulated in the tumor cells, the miR-222 is
reported to be down-regulated in ovarian epithelial carci-
nomas [74]. Furthermore, higher expression of miR-18a
and lower expression of let-7b and miR-199a were shown
to be correlated with serous ovarian carcinoma [78]. In
another study, miR17-5p and let-7b were found to be
involved in the regulation of development and function
of the ovarian corpus luteum specially angiogenesis of
corpus luteum [23]. Interestingly, nearly all of these 11
selected miRNAs (Figure 6) in the present study are
reported to be differentially regulated in endometrium of
women with and without endometriosis [79]. Taken
together, our findings and other evidences support the rel-
evance of these 11 miRNAs to ovarian physiology and
may be the most important regulatory miRNA group in
ovary, as their predicted and analyzed target genes are
involved in a broad range of signaling cascades and path-
ways of the ovarian function.
Conclusion
The presence of distinct miRNAs and other small RNAs,
with different expression patterns and various target genes
in bovine ovary revealed the potential role of such miR-
NAs in follicular development in particular and female
fertility in general. Further functional characterization of
some selected miRNAs including expression profiling and
in situ localization in the ovarian follicles at different
cyclic stages will supplement the results of this study and
help to elucidate their specific roles in the ovarian func-
tion. The information we generated from this study will
help to identify candidate miRNAs targeting specific
molecular and cellular pathways important for ovarian
follicular development, atresia, ovulation as well as ovar-
ian dysfunction.
Methods
Isolation of Small RNAs and subsequent miRNAs 
fractionation
Bovine ovaries were obtained from a cyclic heifer with the
age of 30 months at a stage of mid cycle with a visible
mature corpus luteum including normally distributed dif-
ferent types of follicles. Small RNA samples from various
bovine tissues and cells were isolated using mirVana
miRNA isolation kit (Applied Biosystems Inc, Foster City,
CA) according to the manufacturer's instructions. For
cloning, 10 μg of the ovarian small RNA was loaded into
12% denaturing poly acrylamide gel electrophoresis with
size markers miSPIKE (Integrated DNA Technologies,
Inc., Iowa, USA) and fractions of 18-26 nt were recovered
using DTR gel filtration cartridge (Edge BioSystems, Mar-
yland, USA).
Cloning of small RNAs
For cloning the small RNAs, we followed "5' Ligation
independent Cloning" to ensure complete recovery of
conventional small RNAs as well as small RNAs with 5'
modifications or non-standard 5' ends. All the linkers and
primers were obtained from Integrated DNA Technolo-
gies, Inc., Iowa, USA. List and sequence of linkers and
primers are given in additional file 4. Briefly, once the
enriched small RNA fraction was recovered from the acry-
lamide gel slice, the small RNAs were ligated with a 3'
linker - adenylated oligos, modified with a 3'-terminal
dideoxy-C (ddC) containing Ban-I restriction site [5]. The
ligated products were loaded on dPAGE for purification
and reverse transcription was performed. An exonuclease
digestion was carried out after first strand cDNA synthesis
and then a second 3' ligation was carried out using a dif-
ferent linker sequences. The second 3' linkered product
(60 nt) was purified from dPAGE to remove free linkers.
Subsequently, the amplification of the RT-PCR product
was performed using linker specific primer set with the
thermocycler program of 95.0°C for 10 minutes, 35 cycles
of (95.0°C for 30 seconds, 52.0°C for 30 seconds 72.0°C
for 30 seconds) and followed by incubation at 72.0°C for
5 minutes. Then, the amplicon was subjected to Ban I
digestion, concatemerization and end filling with non-
template adenosine followed by cloning into TOPO TA
Cloning® vector (Invitrogen, Carlsbad, CA). Concatemer
clones were picked up, cultured and then colony PCR was
performed for screening the insert size. Plasmid DNA
preparation and DNA sequencing were performed for
screened clones and small RNAs which were separated by
well defined linker units with the reconstituted Ban I site.
Bioinformatic analysis of small RNA sequences
The small RNA sequences were first compared with the
sequences in miRBase [32,80-82]. Small RNAs completely
or partially matched by less than two mismatches to any
registered miRNA in miRBase were considered putative
bovine miRNA. The remaining sequences were compared
to the bovine nucleotide collection (nr/nt) and the
expressed sequence tags (EST) database in NCBI [83] and
different noncoding RNA databases [84-88]. Sequences,
which were matched 100% to any mRNA, rRNA or tRNA
were excluded from further evaluation to generate novel
miRNA candidates. All the remaining sequences and the
putative bovine miRNA sequences were submitted toBMC Genomics 2009, 10:443 http://www.biomedcentral.com/1471-2164/10/443
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BLAST-search in the Ensembl 52: bovine genome assem-
bly (Btau_4.0) [35] and the 75 bp genomic flanking
sequence upstream from the 3' end or downstream from
the 5' end of the miRNA was considered putative precur-
sor of the matching miRNA.
All the putative precursor sequences were analyzed for
hairpin structure using the mfold Web server (version 3.2)
[89] to evaluate the ability to form thermodynamically
stable hairpin structures [90] based on other criteria
described elsewhere [32]. Chromosome locations, orien-
tation and genomic features of the predicted miRNA pre-
cursors as well as other small RNAs sequences (not
meeting miRNAs criteria) and whether they were located
in intragenic or intergenic genomic regions were deter-
mined using ensembl. Other small RNAs were categorized
according to published research articles [26,27,33].
Detection of miRNAs expression by semi-quantitative 
RT-PCR
Small RNA samples isolated from the 11 different tissues
and cells, such as ovarian cortex, fetal ovary at about six
month of pregnancy, cumulus cells, matured corpus
luteum, oviduct (entire), uterus (horn), placenta, heart,
liver, lung and spleen were used for the detection of miR-
NAs by PCR method according to Ro et al [91] with some
modifications. Briefly, the poly (A)-tailed small RNA was
purified by acid phenol: chloroform: iso-amyl alcohol
and ethanol precipitation method. All small RNA-cDNA
samples were diluted to the same concentration of 6 ng/μl
(which was the lowest amount obtained from cumulus
cells). Three microliters of cDNA was used as template for
conventional PCR and the products were analyzed on a
2% agarose gel. List of primers and oligos used are shown
in the additional file 4. Some representative RT-PCR prod-
ucts were cloned into PGEM-T easy vector (Promega Cor-
poration, Wisconsin, USA) and transformed to E. coli and
sequenced to verify the specificity of PCR amplification.
In situ hybridization of miRNAs in ovarian cryo-sections 
and whole mount COCs
For in-situ hybridization of miRNAs, bovine ovary (21/0)
days of estrus cycle was fixed in 4% PFA overnight at 4°C
followed by overnight incubation in PBS with 30%
sucrose at 4°C and frozen in Tissue-Tek OCT reagent
(Sakura Finetek, Zoeterwoude, NL). Cryo-sections (10
μm) preparation, post-fixation, acetylation and protein-
ase K treatment were carried out as described previously
[92]. Two hours of pre-hybridization was performed at
52°C in hybridization solution (50% formamide, 5×
sodium chloride/sodium citrate [SSC; pH 6.0], 0.1%
Tween-20, 50 μg/ml heparin, and 500 mg/ml yeast tRNA).
Ovarian sections were incubated overnight at 52°C with
3'-Digoxigenin (DIG) labeled LNA-modified oligonucle-
otide probes (1 pM) for miR-29a, U6 RNA and scrambled
miR (Exiqon, Vedbaek, Denmark) in hybridization buffer
in a humidified chamber. Blocking, incubation with anti-
DIG-AP antibody, washing and color development using
Fast Red reaction was performed as described previously
[92]. The slides were mounted with VectaShield contain-
ing DAPI (Vector laboratories, Burlingame, CA) and ana-
lyzed by confocal laser scanning microscope (CLSM LSM-
510, Carl Zeiss, Germany). For whole mount in-situ
hybridization, cumulus oocyte complexes were aspirated
from more than 8 mm of ovarian follicles. Pre-fixation,
processing, digestion with Proteinase K, pre-hybridiza-
tion, hybridization, post-hybridization washing was per-
formed in 4-well embryo culture dishes according to the
high-resolution whole mount in situ hybridization proto-
col from Exiqon. The rest of the procedures were similar
to cryo-section hybridization protocol.
Prediction and analysis of ovarian miRNA targets
For this purpose, initially a raw list of all genes found to
be targeted by our cloned miRNA was generated using
MIRANDA algorithm, miRBase target version 5 [93]. Sub-
sequently, about 800 distinct important genes related to
mammalian reproductive system development, function
and disorders were extracted from Ingenuity knowledge
base (IPA 7.0) by key word search. Then, we applied two
filtration steps to generate a comprehensive list of target
genes. Firstly, raw target set and genes set extracted from
database were cross-matched and common genes were
extracted. Secondly, we applied the condition that multi-
ple genes targeted by multiple miRNAs from the common
target list. From these screened target sets, 11 miRNAs
having the highest number as well as overlapping target
genes were enlisted. Then, the Gene Ontology (GO) anal-
ysis of the screened and sub sets of miRNAs target genes
were performed in order to predict the possible biological
processes and functions that were most likely to be
affected by miRNAs using web delivered tools of Ingenu-
ity Pathway Analysis (Redwood City, California). Top sig-
nificant GO categories, biological functions and different
canonical pathways were analyzed for miRNA specific tar-
gets as well as for all screened targets based on significant
over-representation of genes using a selected threshold for
p-values ≤ 0.05 of hypergeometric distribution [94].
Note
We have submitted our newly identified miRNAs into the
miR-base and they are annotated accordingly.
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